Table 1 Summary of the clinicopathological features of the patients stratified by LN status
From: Expression of EMT-related genes in lymph node metastasis in endometrial cancer: a TCGA-based study
Variables | LN-negative (n = 423) | LN-positive (n = 75) |
|---|---|---|
Age (years), mean ± SD | 63.8 ± 11.1 | 63.3 ± 10.4 |
Race, n (%) | ||
 White | 294 (69.5%) | 45 (60.0%) |
 Black or African American | 78 (18.4%) | 21 (28.0%) |
 Asian | 17 (4.0%) | 2 (2.7%) |
 Others | 8 (1.9%) | 3 (4.0%) |
Tumor grade, n (%) | ||
 Grade1 | 95 (22.5%) | 2 (2.7%) |
 Grade2 | 109 (25.8%) | 8 (10.7%) |
 Grade3 | 219 (51.8%) | 65 (86.7%) |
Histological subtype, n (%) | ||
 Endometrioid | 350 (82.7%) | 35 (46.7%) |
 Non-endometrioid | 73 (17.3%) | 40 (53.3%) |
MI, n (%) | ||
  < 1/2 | 285 (67.4%) | 26 (34.7%) |
  ≥ 1/2 | 138 (32.6%) | 49 (65.3%) |
Molecular subtype, n (%) | ||
 POLE | 39 (9.2%) | 8 (10.7%) |
 MSI-H | 134 (31.7%) | 14 (18.7%) |
 CNL | 139 (32.9%) | 10 (13.3%) |
 CNH | 103 (24.3%) | 42 (56.0%) |
 Missing | 8 (1.9%) | 1 (1.3%) |